» Articles » PMID: 17130747

Effects of Bovine Alpha-lactalbumin and Casein Glycomacropeptide-enriched Infant Formulae on Faecal Microbiota in Healthy Term Infants

Overview
Publisher Wiley
Date 2006 Nov 30
PMID 17130747
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Certain milk factors may promote the growth of a host-friendly gastrointestinal microbiota, for example, one that is predominated by bifidobacteria, a perceived health-promoting genus. This may explain why breast-fed infants experience fewer intestinal infections than their formula-fed counterparts who are believed to have a more diverse microbiota, which is similar to that of adults. The effects of formulas supplemented with 2 such ingredients from bovine milk, alpha-lactalbumin (alpha-lac) and casein glycomacropeptide (GMP), on gut flora were investigated in this study.

Patients And Methods: Six-week-old (4-8 wk), healthy term infants were randomised to a standard infant formula or 1 of 2 test formulae enriched in alpha-lac with higher or lower GMP until 6 months. Faecal bacteriology was determined by the culture-independent procedure fluorescence in situ hybridisation.

Results: There was a large fluctuation of bacterial counts within groups with no statistically significant differences between groups. Although all groups showed a predominance of bifidobacteria, breast-fed infants had a small temporary increase in counts. Other bacterial levels varied in formula-fed groups, which overall showed an adult-like faecal microflora.

Conclusions: It can be speculated that a prebiotic effect for alpha-lac and GMP is achieved only with low starting populations of beneficial microbiota (eg, infants not initially breast-fed.

Citing Articles

Effects of Infant Formula Supplemented With Prebiotics on the Gut Microbiome, Gut Environment, Growth Parameters, and Safety and Tolerance: A Systematic Review and Meta-Analysis.

Kebbe M, Leung K, Perrett B, Reimer R, Adamo K, Redman L Nutr Rev. 2025; 83(3):422-447.

PMID: 39832301 PMC: 11819492. DOI: 10.1093/nutrit/nuae184.


Glycomacropeptide as an Efficient Agent to Fight Pathophysiological Mechanisms of Metabolic Syndrome.

Sauve M, Feldman F, Sane A, Koudoufio M, Patey N, Spahis S Nutrients. 2024; 16(6).

PMID: 38542783 PMC: 10974946. DOI: 10.3390/nu16060871.


Milk Bioactive Compounds and Gut Microbiota Modulation: The Role of Whey Proteins and Milk Oligosaccharides.

Gallo V, Arienzo A, Tomassetti F, Antonini G Foods. 2024; 13(6).

PMID: 38540897 PMC: 10969594. DOI: 10.3390/foods13060907.


Functional proteins in breast milk and their correlation with the development of the infant gut microbiota: a study of mother-infant pairs.

Xi M, Liang D, Yan Y, Duan S, Leng H, Yang H Front Microbiol. 2023; 14:1239501.

PMID: 37771701 PMC: 10524269. DOI: 10.3389/fmicb.2023.1239501.


The Role of Bovine Kappa-Casein Glycomacropeptide in Modulating the Microbiome and Inflammatory Responses of Irritable Bowel Syndrome.

Qu Y, Park S, Dallas D Nutrients. 2023; 15(18).

PMID: 37764775 PMC: 10538225. DOI: 10.3390/nu15183991.